McKesson Co. (NYSE:MCK) Shares Acquired by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in McKesson Co. (NYSE:MCK - Free Report) by 9.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,103,050 shares of the company's stock after purchasing an additional 95,806 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.87% of McKesson worth $628,639,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Millstone Evans Group LLC acquired a new stake in shares of McKesson during the 4th quarter worth approximately $28,000. Synergy Asset Management LLC purchased a new stake in McKesson in the fourth quarter valued at $32,000. Crews Bank & Trust acquired a new position in shares of McKesson in the 4th quarter valued at $33,000. Atala Financial Inc purchased a new position in shares of McKesson during the 4th quarter worth $34,000. Finally, Graney & King LLC acquired a new stake in shares of McKesson during the 4th quarter worth about $38,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research analysts have commented on MCK shares. Morgan Stanley upped their target price on shares of McKesson from $642.00 to $745.00 and gave the company an "overweight" rating in a research report on Wednesday, April 2nd. Bank of America increased their price objective on shares of McKesson from $755.00 to $800.00 and gave the stock a "buy" rating in a research report on Friday, May 9th. Wall Street Zen downgraded shares of McKesson from a "strong-buy" rating to a "buy" rating in a report on Wednesday, May 21st. Wells Fargo & Company upped their price target on McKesson from $641.00 to $691.00 and gave the stock an "equal weight" rating in a research note on Friday, March 14th. Finally, Evercore ISI raised their price target on McKesson from $650.00 to $675.00 and gave the stock an "outperform" rating in a research report on Thursday, February 6th. Three analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, McKesson presently has an average rating of "Moderate Buy" and a consensus target price of $686.69.

Insider Activity at McKesson

In other news, CFO Britt J. Vitalone sold 6,336 shares of McKesson stock in a transaction dated Thursday, May 22nd. The stock was sold at an average price of $717.30, for a total transaction of $4,544,812.80. Following the sale, the chief financial officer now owns 14,760 shares in the company, valued at approximately $10,587,348. The trade was a 30.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CAO Napoleon B. Rutledge, Jr. sold 543 shares of the company's stock in a transaction dated Monday, May 19th. The shares were sold at an average price of $726.51, for a total value of $394,494.93. Following the completion of the sale, the chief accounting officer now directly owns 1,972 shares of the company's stock, valued at approximately $1,432,677.72. This trade represents a 21.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 8,127 shares of company stock valued at $5,834,498 over the last three months. 0.11% of the stock is owned by corporate insiders.

McKesson Stock Up 0.7%

McKesson stock traded up $4.80 during trading on Monday, reaching $715.44. The stock had a trading volume of 815,972 shares, compared to its average volume of 918,692. McKesson Co. has a 52-week low of $464.42 and a 52-week high of $731.00. The stock has a market cap of $89.51 billion, a PE ratio of 32.76, a P/E/G ratio of 1.29 and a beta of 0.53. The business has a 50 day moving average price of $689.88 and a 200 day moving average price of $634.48.

McKesson (NYSE:MCK - Get Free Report) last issued its earnings results on Thursday, May 8th. The company reported $10.12 EPS for the quarter, topping analysts' consensus estimates of $9.83 by $0.29. McKesson had a net margin of 0.82% and a negative return on equity of 181.26%. The firm had revenue of $90.82 billion during the quarter, compared to the consensus estimate of $94 billion. During the same quarter in the previous year, the firm posted $6.18 earnings per share. The company's revenue was up 18.9% compared to the same quarter last year. On average, equities analysts predict that McKesson Co. will post 32.77 EPS for the current fiscal year.

McKesson Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 1st. Investors of record on Monday, June 2nd will be paid a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 0.40%. The ex-dividend date is Monday, June 2nd. McKesson's payout ratio is 10.99%.

McKesson Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.